© Copyright RiverVest® All Rights Reserved.
OncoResponse is leveraging a proprietary human antibody platform to discover novel targets and identify fully-human monoclonal antibodies as therapeutics for the treatment of cancer, potentially extending cures to patients who otherwise would not respond to immunotherapy.
© Copyright RiverVest® All Rights Reserved.